Daniel Geffken

Daniel Geffken is the Founder and Managing Director of Danforth Advisors, a company that partners with life science companies to provide specialized services in finance, accounting, and operations. With a MBA from Harvard Business School and a B.S. in Economics from The Wharton School, Daniel holds various positions as Chief Financial Officer and Senior Financial Advisor in multiple companies such as Eloxx Pharmaceuticals, Olaris, Inc, Locust Walk Acquisition Corp., Affini-T, Myeloid Therapeutics, Century Therapeutics, LLC, CalciMedica, Dermbiont Therapeutics, and Matrivax Corporation.